Ophthalmic Company GrayBug to Present at BIO CEO & Investor Conference on February 8
BALTIMORE, MD -- (Marketwired) -- 02/04/16 -- GrayBug, Inc., a venture-stage pharmaceutical company developing microparticle controlled release drug delivery technologies for the treatment of ocular diseases including wet age-related macular degeneration ( …